💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Esperion Therapeutics, Inc. (ESPR)
« Back to company indexESPR Chatter Timeline
Stock Ticker for ESPR
Most Active Tweeters for ESPR
| User | Tweets |
|---|---|
| @atwoodct | 8 |
| @Tickeron | 8 |
| @AniuStudent | 3 |
| @newsfilterio | 3 |
| @TradeWithAlerts | 3 |
Recent Tweets for ESPR
 |
@Tickeron $ESPR's price moved below its 50-day Moving Average on March 18, 2021. View odds for this and other indicators:… https://t.co/ZIq23q3arn April 19th 2021, 5:04am |
|
@Tickeron $ESPR's price moved below its 50-day Moving Average on March 18, 2021. View odds for this and other indicators:… https://t.co/PMNIsDYmGT April 17th 2021, 1:04am |
 |
@ChampionVibe new trade set-up $ESPR https://t.co/PmcPGu2PwV (NFA) April 16th 2021, 3:04pm |
 |
@atwoodct $ESPR Friday script numbers were horrible. April 16th 2021, 1:04pm |
|
@Tickeron $ESPR's price moved below its 50-day Moving Average on March 18, 2021. View odds for this and other indicators:… https://t.co/8lHhT7L37T April 16th 2021, 2:04am |
 |
@mediasentiment $ESPR new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 645 April 15th 2021, 11:04pm |
 |
@newsfilterio Form DEF 14A (other definitive proxy statements) filed with the SEC $ESPR https://t.co/5EaYmq7h7P April 15th 2021, 8:04pm |
 |
@fintel_io $ESPR / Esperion Therapeutics files form DEF 14A https://t.co/IwLSIXeG7y April 15th 2021, 8:04pm |
 |
@FlashAlert_me $ESPR [15s. delayed] filed form DEF 14A on April 15, 16:02:18 https://t.co/qqPkCLjd7F April 15th 2021, 8:04pm |
 |
@TradeWithAlerts Large Print $ESPR Size: 129361 Price: 27 Time: 1529 Amount: $3,492,747.00 April 15th 2021, 7:04pm |
|
@TradeWithAlerts Large Print $ESPR Size: 129361 Price: 27 Time: 1525 Amount: $3,492,747.00 April 15th 2021, 7:04pm |
|
@TradeWithAlerts Large Print $ESPR Size: 129361 Price: 27 Time: 1523 Amount: $3,492,747.00 April 15th 2021, 7:04pm |
 |
@prosperousguy @Eminyel @egelandd I like this chart on $ESPR $27.40, maybe a failed breakdown and now reversal https://t.co/3IWWGD8ssh April 14th 2021, 3:04pm |
 |
@Gambiste1 RT @Eminyel: @egelandd $ESPR is loaded with institutions April 14th 2021, 3:04pm |
 |
@Eminyel @egelandd $ESPR is loaded with institutions April 14th 2021, 3:04pm |
 |
@AniuStudent @pki58 I heard it & similar $ESPR comments previously. Some r mad this ROW deal isn’t here yet based on these remar… https://t.co/Wdubpwee9a April 14th 2021, 12:04pm |
|
@AniuStudent As 4 an $ESPR ROW deal, I’m indifferent. With no ROW deal now, it could be bad news- that none could be reached yet… https://t.co/XqlIjflDye April 13th 2021, 10:04pm |
|
@AniuStudent I disagree. $ESPR mid-single digit increases in sales weekly (in a global pandemic), expanding EU sales markets & C… https://t.co/SlJTXD1v6w April 13th 2021, 9:04pm |
|
@atwoodct $ESPR Watching this. CEO looks nervous. I mean previously he was a cheerleader. Today he looks like failure. C… https://t.co/H814HalL5j April 13th 2021, 1:04pm |
|
@Tickeron $ESPR in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/ctedplT2eb April 13th 2021, 8:04am |
|
@newsfilterio Esperion to Report First Quarter 2021 Financial Results May 4, 2021 $ESPR https://t.co/jcYj2OnHbP April 13th 2021, 12:04am |
 |
@otcdynamics $ESPR Esperion to Report First Quarter 2021 Financial Results May 4, 2021 https://t.co/oSjSRcQ3s8 April 12th 2021, 8:04pm |
 |
@StckPro $ESPR NEW ARTICLE : Esperion to Report First Quarter 2021 Financial Results May 4, 2021 https://t.co/XGjCMqDnci Get… https://t.co/s8YypJ6ICJ April 12th 2021, 8:04pm |
|
@FlashAlert_me $ESPR [15s. delayed]: Issued Press Release on April 12, 16:01:00: Esperion to Report First Quarter 2021 Financial R… https://t.co/txayZ0iKnq April 12th 2021, 8:04pm |
 |
@stock_titan $ESPR Esperion to Report First Quarter 2021 Financial Results May 4, 2021 https://t.co/1UZG472vcE April 12th 2021, 8:04pm |
|
@atwoodct $espr Tim M blocked my emails. I guess he doesn't want to hear the truth. April 12th 2021, 4:04pm |
|
@atwoodct $ESPR. An absolute portfolio killer. There is no hope here. CEO should resign immeidately April 12th 2021, 3:04pm |
|
@atwoodct $ESPR. This is a loser. It's going much lower. Now is the time to just realize maybe in ten years this might get even April 12th 2021, 3:04pm |
|
@Tickeron $ESPR in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/EuEU0AJm6Z April 12th 2021, 12:04pm |
|
@atwoodct $espr. Drug is not selling. 52 week low soon. Tim CEO of the year April 9th 2021, 3:04pm |
|
@atwoodct $espr. That guy only posted rumor once about Friday scripts. After that, nothing. I guess scripts are horrible a… https://t.co/HHBlmNPenZ April 9th 2021, 10:04am |
|
@Tickeron $ESPR in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/rbbOU9Hmze April 9th 2021, 5:04am |
 |
@tradersreport RT @Tickeron: $ESPR in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators: https://t.co/xD0vZs6YFa #Es… April 8th 2021, 7:04am |
|
@Tickeron $ESPR in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/EWFUM7mfBY April 8th 2021, 7:04am |
|
@Tickeron $ESPR's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/ygStAxCwIZ April 7th 2021, 12:04pm |
|
@newsfilterio Esperion to Participate in Fireside Chat at the 20th Annual Needham Virtual Healthcare Conference $ESPR https://t.co/5csAJMQuIG April 7th 2021, 4:04am |
|
@atwoodct $ESPR no pumping in awhile. Did everyone sell? April 6th 2021, 5:04pm |
 |
@SmallCapsDaily $ESPR Esperion to Participate in Fireside Chat at the 20th Annual Needham Virtual Healthcare Conference GlobeNewswi… https://t.co/C92VOgGirx April 6th 2021, 3:04pm |
|
@stock_titan $ESPR Esperion to Participate in Fireside Chat at the 20th Annual Needham Virtual Healthcare Conference https://t.co/xRsxA0hrUf April 6th 2021, 12:04pm |
 |
@DavidVGoliath6 Wow, what happened, short sellers don’t fear @wallstreetbets anymore? $ESPR the most heavily shorted stock since Ma… https://t.co/xnHDw3VeXh April 5th 2021, 1:04am |
|
@mediasentiment $ESPR new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 183 April 3rd 2021, 11:04pm |
|
@Tickeron $ESPR in +4.63% Uptrend, growing for three consecutive days on April 1, 2021. View odds for this and other indicato… https://t.co/vRDiLmdySb April 3rd 2021, 11:04pm |
 |
@ChrisGeer12 $ESPR nice tap off middle bb but really needs to close over top of it or above that low 29 line, which would give i… https://t.co/sJwtXzdQnD April 3rd 2021, 6:04pm |
|
@mediasentiment $ESPR new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 4 April 3rd 2021, 7:04am |
|
@Tickeron $ESPR in +4.63% Uptrend, growing for three consecutive days on April 1, 2021. View odds for this and other indicato… https://t.co/4KyDY8x8zm April 3rd 2021, 6:04am |
|
@Eminyel @egelandd @jayabacus Goooooo $ESPR I think eventually it’s $200+ April 2nd 2021, 1:04pm |
|
@atwoodct $ESPR. Thoughts on missing their second deadline for ROW deal and nothing from the CEO on why? Either incompeten… https://t.co/LWN6wX9IAY April 1st 2021, 1:04am |
 |
@Bond00692 @mirazaslove @LuoshengPeng I hope so. I’m only holding $cvm and $espr now. Been taking a little time off and holdin… https://t.co/0E2FKnI9M7 March 31st 2021, 8:03pm |
|
@BH1377 Investors should hope that $ESPR gets the best possible ROW deal instead of meeting the EOQ1 date that's meaningles… https://t.co/CCqyBxLhRs March 31st 2021, 3:03pm |
 |
@timfris @lblegend33 And miss the halt and $ESPR buyout? (Wishful thinking) March 31st 2021, 2:03pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
